Study type | No. of studies | Median no. of patients | Patient-centred primary outcome, n (%) | Median LFU (days) | OMERACT, n (%) | Falder outcome, n (%) | |||
---|---|---|---|---|---|---|---|---|---|
Mortality | Life impact | Resource/economic | Pathophys. | ||||||
RCT | 53 | 43 | 20 (37) | 3 | 24 (45) | 18 (33) | 13 (25) | 41 (77) | 17 (32) |
Pseudo-RCT | 13 | 31 | 3 (23) | 7 | 9 (69) | 0 (0) | 4 (30) | 12 (92) | 2 (15) |
CSWCC | 19 | 30 | 6 (31) | 28 | 11 (58) | 6 (32) | 5 (26) | 14 (74) | 5 (26) |
ISWCC | 13 | 40 | 3 (23) | 12 | 10 (77) | 3 (23) | 8 (62) | 11 (85) | 2 (15) |